Clinical consequences of polypharmacy in elderly: Expect the unexpected, think the unthinkable

Expert Opinion on Drug Safety

Volumn 6, Issue 6, 2007, Pages 695-704

  Salazar, Joel A ^a   Poon, Ivy ^b   Nair, Mridula ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adverse effects; Drug interactions; Elderly; Medications; Polypharmacy

Indexed keywords

ANTICOAGULANT AGENT; ATROPINE PLUS DIPHENOXYLATE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; CETIRIZINE; CLARITHROMYCIN; COTRIMOXAZOLE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMOTRIGINE; LEVODOPA; LITHIUM; MAPROTILINE; METFORMIN; MIDAZOLAM; NEFAZODONE; NIFEDIPINE; POTASSIUM SPARING DIURETIC AGENT; QUETIAPINE; RANITIDINE; SEROTONIN UPTAKE INHIBITOR; TACROLIMUS; TERBINAFINE; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WARFARIN; XANTAC;

CORTICOSTEROID THERAPY; DAIRY PRODUCT; DISEASE EXACERBATION; DOSE KIDNEY FUNCTION RELATION; DOSE RESPONSE; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; FOOD; FOOD DRUG INTERACTION; GERIATRIC CARE; GRAPEFRUIT; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; MEDICATION ERROR; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PHARMACODYNAMICS; POLYPHARMACY; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT RESPONSE; AGED; ANIMAL; DRUG INTERACTION; PHYSIOLOGY;

AGED; ANIMALS; DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; HUMANS; MEDICATION ERRORS; POLYPHARMACY;

EID: 38449113758     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.6.6.695     Document Type: Review

References (60)